BioStem Technologies, Inc
Fundamentals
Oldest to newest| Line | Dec 2025 |
|---|---|
| Revenue | $47.5M |
| Gross profit | $44.4M |
| Operating income | −$689,147 |
| Net income | −$6.6M |
| Operating cash flow | $9.9M |
| Free cash flow | $6.6M |
| Cash | $29.5M |
| Debt | $0.00 |
| Shares outstanding | 16.7M |
| Line | Dec 2025 |
|---|---|
| Revenue | $47.5M |
| Gross profit | $44.4M |
| Operating income | −$689,147 |
| Net income | −$6.6M |
| Operating cash flow | $9.9M |
| Free cash flow | $6.6M |
| Cash | $29.5M |
| Debt | $0.00 |
| Shares outstanding | 16.7M |